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Abstract
In June 2012, Israeli guidelines for laboratories were published deﬁning the recommended methods for diagnosis of Clostridium difﬁcile
infection (CDI). We conducted this survey to examine the effects of the new recommendations on the proportions of rejected and positive
samples by the different methods. A survey was mailed to the directors of all general hospital (GH) and health maintenance organization
(HMO) clinical microbiology laboratories. The report was divided into two periods, before and after implementation of the guidelines.
Surveys were completed by 13/28 GH laboratories and 5/6 HMO laboratories. All 18 of these laboratories used C. difﬁcile toxin (CDT)
enzyme immunoassay alone during the ﬁrst period of the survey. In the second period, nine laboratories (Group A) used CDT-PCR: two of
them used this method exclusively while the other seven used it to resolve most (>90%) of the discrepant results (glutamate dehydrogenase
antigen (GDH) +/CDT]. The other nine laboratories (Group B) used combined GDH/CDT assay, using CDT PCR in only a minority
(< 20%) of GDH+/CDT cases. The overall proportion of rejected samples increased from 9.5% in the ﬁrst period to 13.9% in the second
(p <0.001). Between the ﬁrst and second periods the proportion of positive samples increased from 9.0% to 11.6% in group A laboratories
(p <0.001), but decreased from 12.9% to 9.7% in group B laboratories (p <0.001). Implementation of the guidelines has resulted in a
signiﬁcant increase in the proportion of rejected samples and in the proportion testing positive, suggesting more appropriate test utilization
and improved sensitivity in the laboratory diagnosis of CDI.
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Abstract
We aim to evaluate the epidemiology and outcome of gram-negative prosthetic joint infection (GN-PJI) treated with debridement,
antibiotics and implant retention (DAIR), identify factors predictive of failure, and determine the impact of ciproﬂoxacin use on prognosis.
We performed a retrospective, multicentre, observational study of GN-PJI diagnosed from 2003 through to 2010 in 16 Spanish hospitals.
We deﬁne failure as persistence or reappearance of the inﬂammatory joint signs during follow-up, leading to unplanned surgery or repeat
debridement >30 days from the index surgery related death, or suppressive antimicrobial therapy. Parameters predicting failure were
analysed with a Cox regression model. A total of 242 patients (33% men; median age 76 years, interquartile range (IQR) 68–81) with 242
episodes of GN-PJI were studied. The implants included 150 (62%) hip, 85 (35%) knee, ﬁve (2%) shoulder and two (1%) elbow prostheses.
There were 189 (78%) acute infections. Causative microorganisms were Enterobacteriaceae in 78%, Pseudomonas spp. in 20%, and other
gram-negative bacilli in 2%. Overall, 19% of isolates were ciproﬂoxacin resistant. DAIR was used in 174 (72%) cases, with an overall success
rate of 68%, which increased to 79% after a median of 25 months’ follow-up in ciproﬂoxacin-susceptible GN-PJIs treated with ciproﬂoxacin.
Ciproﬂoxacin treatment exhibited an independent protective effect (adjusted hazard ratio (aHR) 0.23; 95% CI, 0.13–0.40; p <0.001),
whereas chronic renal impairment predicted failure (aHR, 2.56; 95% CI, 1.14–5.77; p 0.0232). Our results conﬁrm a 79% success rate in
ciproﬂoxacin-susceptible GN-PJI treated with debridement, ciproﬂoxacin and implant retention. New therapeutic strategies are needed for
ciproﬂoxacin-resistant PJI.
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Abstract
Detection of microorganisms by blood cultures (BCs) is essential in managing patients with bacteraemia. Rather than the number of
punctures, the volume of blood drawn is considered paramount in efﬁcient and reliable detection of microorganisms. We performed a
1-year prospective multicentre study in adult emergency departments of three French university hospitals comparing two methods for BCs:
a unique blood culture (UBC) collecting a large volume of blood (40 mL) and the standard method of multiple blood cultures (MBC). The
performances of both methods for bacterial contamination and efﬁcient microbial detection were compared, each patient serving as his own
control. Amongst the 2314 patients included, three hundred were positive for pathogens (n = 245) or contaminants (n = 55). Out of the
245 patients, 11 were positive for pathogens by UBC but negative by MBC and seven negative by UBC but positive by MBC (p 0.480). In the
subgroup of 137 patients with only two BCs, UBC was superior to MBC (p 0.044). Seven and 17 patients had contaminated BCs by UBC and
MBC only, respectively (p 0.062). Considering the sums of pathogens missed and contaminants, UBC signiﬁcantly outperformed MBC (p
0.045). Considering the complete picture of cost savings, efﬁcient detection of microorganisms and decrease in contaminations, UBC offers
an interesting alternative to MBC.
Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical
characteristics and risk factors
M.-H. Tsai1,2,3,4, S.-M. Chu2,5, C.-W. Lee3,4, J.-F. Hsu2,5, H.-R. Huang2,5, M.-C. Chiang2,5, R.-H. Fu2,5, R. Lien2,5 and Y.-C. Huang2,6
1) Division of Neonatology and Pediatric Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Yunlin, 2) College of Medicine, Chang
Gung University, Taoyuan,, 3) Department of Nursing, Division of Basic Medical Sciences, and Chronic Diseases and Health Promotion Research Center, Chang
Gung University of Science and Technology, Chiayi,, 4) Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology,
Taoyuan,, 5) Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, and 6) Division of Pediatric Infectious Disease,
Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Original Submission: 11 November 2013; Accepted: 28 April 2014
Editor: Editor; D. Raoult
Article published online: 2 May 2014
Clin Microbiol Infect 2014; 20: O928–O935
10.1111/1469-0691.12661
Abstract
We aimed to characterize the incidence, clinical features, risk factors and outcomes of recurrent late-onset sepsis (LOS) in the neonatal
intensive care unit (NICU). All neonates with LOS from the NICU of a tertiary-level teaching hospital in northern Taiwan between 2004 and
2011 were enrolled for analyses. A case-control study was performed to determine risk factors for recurrence. Of 713 neonates with LOS,
150 (21.0%) experienced recurrence and 48 (6.7%) had >1 recurrences; c. two-thirds of recurrent LOS occurred in infants with birth weight
(BW) ≦ 1500 g or gestational age (GA) ≦ 30 weeks. The recurrent LOS episodes were signiﬁcantly more severe and had a higher
sepsis-attributable mortality rate than the ﬁrst episodes. The overall in-hospital mortality rate was 30.7% for neonates with recurrent LOS
and 7.8% for those with single LOS (odds ratio (OR), 5.22; 95% CI, 3.28–8.30). When both BW and GA were controlled, neonates with
recurrent LOS had a signiﬁcantly prolonged hospitalization compared with the controls (median 109 vs. 84 days, p <0.001). After
multivariate logistic regression, longer duration of total parenteral nutrition (TPN; OR, 1.30; 95% CI, 1.10–1.52 for every 10-day increment),
presence of congenital anomalies (OR, 2.64; 95% CI, 1.10–6.35) and neurological co-morbidities (OR, 4.14; 95% CI, 1.14–15.10) were
identiﬁed as the independent risk factors for LOS recurrence. We concluded that c. one-ﬁfth of neonates with LOS had recurrence, which
signiﬁcantly resulted in prolonged hospitalization and increased mortality. Longer TPN administration, presence of congenital anomalies and
neurological co-morbidities are independently associated with recurrent LOS.
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